SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-050131
Filing Date
2020-02-26
Accepted
2020-02-26 16:35:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d846727dsc13da.htm SC 13D/A 47013
2 EX-99.A d846727dex99a.htm EX-99.A 74110
3 EX-99.B d846727dex99b.htm EX-99.B 73278
  Complete submission text file 0001193125-20-050131.txt   195775
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43603 | Film No.: 20656298
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 5251 DTC PARKWAY, SUITE 285 GREENWOOD VILLAGE CO 80111
Business Address
Scott John K Jr. (Filed by) CIK: 0001753763 (see all company filings)

Type: SC 13D/A